Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaques.

Safronetz D, Rockx B, Feldmann F, Belisle SE, Palermo RE, Brining D, Gardner D, Proll SC, Marzi A, Tsuda Y, Lacasse RA, Kercher L, York A, Korth MJ, Long D, Rosenke R, Shupert WL, Aranda CA, Mattoon JS, Kobasa D, Kobinger G, Li Y, Taubenberger JK, Richt JA, Parnell M, Ebihara H, Kawaoka Y, Katze MG, Feldmann H.

J Virol. 2011 Feb;85(3):1214-23. doi: 10.1128/JVI.01848-10. Epub 2010 Nov 17.

2.

Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets.

McCullers JA, McAuley JL, Browall S, Iverson AR, Boyd KL, Henriques Normark B.

J Infect Dis. 2010 Oct 15;202(8):1287-95. doi: 10.1086/656333.

3.

Postinfluenza bacterial pneumonia: host defenses gone awry.

Ballinger MN, Standiford TJ.

J Interferon Cytokine Res. 2010 Sep;30(9):643-52. doi: 10.1089/jir.2010.0049. Review.

4.

Interaction between influenza virus and Streptococcus pneumoniae in severe pneumonia.

Madhi SA, Schoub B, Klugman KP.

Expert Rev Respir Med. 2008 Oct;2(5):663-72. doi: 10.1586/17476348.2.5.663.

PMID:
20477301
5.

Prior infection with classical swine H1N1 influenza viruses is associated with protective immunity to the 2009 pandemic H1N1 virus.

Kash JC, Qi L, Dugan VG, Jagger BW, Hrabal RJ, Memoli MJ, Morens DM, Taubenberger JK.

Influenza Other Respir Viruses. 2010 May 1;4(3):121-7. doi: 10.1111/j.1750-2659.2010.00132.x.

6.

Epithelial repair mechanisms in the lung.

Crosby LM, Waters CM.

Am J Physiol Lung Cell Mol Physiol. 2010 Jun;298(6):L715-31. doi: 10.1152/ajplung.00361.2009. Epub 2010 Apr 2. Review.

7.

Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections.

Gill JR, Sheng ZM, Ely SF, Guinee DG, Beasley MB, Suh J, Deshpande C, Mollura DJ, Morens DM, Bray M, Travis WD, Taubenberger JK.

Arch Pathol Lab Med. 2010 Feb;134(2):235-43. doi: 10.1043/1543-2165-134.2.235.

8.

Axis of coinfection evil.

DeLeo FR, Musser JM.

J Infect Dis. 2010 Feb 15;201(4):488-90. doi: 10.1086/650304. No abstract available.

PMID:
20078214
9.

Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza.

Palacios G, Hornig M, Cisterna D, Savji N, Bussetti AV, Kapoor V, Hui J, Tokarz R, Briese T, Baumeister E, Lipkin WI.

PLoS One. 2009 Dec 31;4(12):e8540. doi: 10.1371/journal.pone.0008540.

10.

New look at an old problem: bacterial superinfection after influenza.

Hartshorn KL.

Am J Pathol. 2010 Feb;176(2):536-9. doi: 10.2353/ajpath.2010.090880. Epub 2009 Dec 17. No abstract available.

11.

Pneumococcal pneumonia and influenza: a deadly combination.

Klugman KP, Chien YW, Madhi SA.

Vaccine. 2009 Aug 21;27 Suppl 3:C9-C14. doi: 10.1016/j.vaccine.2009.06.007.

PMID:
19683658
12.

Pathology of human influenza revisited.

Kuiken T, Taubenberger JK.

Vaccine. 2008 Sep 12;26 Suppl 4:D59-66. Review.

13.

Role of sialic acid binding specificity of the 1918 influenza virus hemagglutinin protein in virulence and pathogenesis for mice.

Qi L, Kash JC, Dugan VG, Wang R, Jin G, Cunningham RE, Taubenberger JK.

J Virol. 2009 Apr;83(8):3754-61. doi: 10.1128/JVI.02596-08. Epub 2009 Feb 11.

14.

Time from illness onset to death, 1918 influenza and pneumococcal pneumonia.

Klugman KP, Astley CM, Lipsitch M.

Emerg Infect Dis. 2009 Feb;15(2):346-7. No abstract available.

15.
16.

Planning for an influenza pandemic: thinking beyond the virus.

McCullers JA.

J Infect Dis. 2008 Oct 1;198(7):945-7. doi: 10.1086/592165. No abstract available.

17.

Hydrophobic surfactant proteins and their analogues.

Walther FJ, Waring AJ, Sherman MA, Zasadzinski JA, Gordon LM.

Neonatology. 2007;91(4):303-10. Epub 2007 Jun 7. Review.

PMID:
17575474
18.

Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza.

Smith MW, Schmidt JE, Rehg JE, Orihuela CJ, McCullers JA.

Comp Med. 2007 Feb;57(1):82-9.

19.

Increased plasminogen activator inhibitor-1 concentrations in bronchoalveolar lavage fluids are associated with increased mortality in a cohort of patients with Pseudomonas aeruginosa.

Song Y, Lynch SV, Flanagan J, Zhuo H, Tom W, Dotson RH, Baek MS, Rubio-Mills A, Singh G, Kipnis E, Glidden D, Brown R, Garcia O, Wiener-Kronish JP.

Anesthesiology. 2007 Feb;106(2):252-61.

PMID:
17264718

Supplemental Content

Support Center